Introduction {#Sec1}
============

Bariatric surgery is the only effective method of treating clinical obesity and the demand for this surgery is growing worldwide. If the demand for bariatric surgery increases as expected, while the hospital capacity remains unchanged, new strategies need to be found and implemented aimed at optimizing the peri- and postoperative care. A method for achieving this objective is the fast-track or enhanced recovery after surgery. This includes best practice preoperative preparation and standardization of procedures involved with peri- and postoperative care; all of which would ensure early recovery and improved prognosis \[[@CR1]--[@CR6]\]. Based on this principle, a number of bariatric centers have already implemented the Enhanced Recovery After Bariatric Surgery (ERABS) protocol. We retrospectively compared the operating room logistics and postoperative complications between patients receiving surgery following the pre-ERABS (2013--2014) and ERABS protocol (January to June 2015) in an academic hospital. During both periods, patients underwent one of the following laparoscopic surgeries---Roux-en-Y gastric bypass, sleeve gastrectomy, gastric banding or revisional surgery---in a specialized operating room (Karl Storz OR1™). The primary endpoint was the length of stay in hospital and was measured in days, i.e., the day the patient was admitted until discharge. Secondary endpoints were turnover times (the time required for preparing the operating room for the next case), induction time (from induction of anesthesia until a patient is ready for surgery), surgical time (duration of surgery), procedure time (duration of stay in the operating room), the number of re-admissions, re-operations and complications during admission and within 30 days. Complications were graded using the Clavien−Dindo classification \[[@CR7], [@CR8]\]. The patients were initially qualified for the procedure during their first visit to the clinical surgical advice center, based on International Federation for the Surgery of Obesity (IFSO) criteria.

Statistics {#Sec2}
==========

Differences between the pre-ERABS and ERABS period in continuous data were analyzed using unpaired Student *t* test, and differences in categorical data were analyzed using the chi-squared test. A *p* value \<0.05 was considered statistically significant.

The pre-ERABS protocol {#Sec3}
----------------------

As part of an operating room (OR) schedule, two to three procedures were performed in a day by a team of surgeons, anesthesiologist and OR nurses in one specialized OR (Karl Storz OR1™). Patients received paracetamol 1 g and diazepam 5 mg orally as premedication 1 h before surgery. Pneumatic compression stockings were adjusted and low-molecular-weight heparin 5,000 IU was given subcutaneously for thrombosis prophylaxis. Patients were transported to the OR on the bed and then moved to the operating table. General anesthesia was induced with propofol, sufentanil and rocuronium with the dose adjusted to corrected body weight. After tracheal intubation, anesthesia was maintained with sevoflurane or propofol with intermittent administration of sufentanil to maintain the bispectral index between 40 and 60. Rocuronium was continuously infused with monitoring of the train-of-four (TOF) ratio. Neuromuscular blockade was reversed with atropine and neostigmine on completion of surgery. Administration of anesthetics was discontinued when the TOF ratio recovered to \>90 % and the endotracheal tube removed. Patients were transported to the post-anesthesia care unit (PACU), where patient-controlled analgesia was provided using morphine. Patients were immobilized by compression stockings, urinary catheters and opiates for analgesia and were highly dependent on the nursing staff.

The ERABS protocol {#Sec4}
------------------

Five to six procedures were performed in a day by a dedicated team consisting of fixed surgeons, a dedicated anesthesiologist and OR nurses \[[@CR9], [@CR10]\].

Anesthesia {#Sec5}
==========

Patients received low-molecular-weight heparin 5,000 IU subcutaneously on the evening before surgery. Without premedication, patients without compression stockings walked to the operating room, and then receive a balanced crystalloid solution via a peripheral venous catheter. General anesthesia was induced with sufentanil 10 µg and remifentanil 0.5 µg/kg, followed by continuous infusion at 0.1 µg/kg/min, with propofol 1.5--2 mg/kg and rocuronium 0.6 mg/kg before orotracheal intubation. Doses of these anesthetics were decided based on ideal body weight. The lungs were ventilated to maintain end-tidal carbon dioxide tension between 32 and 35 mmHg with a positive end-expiratory pressure of 3--10 cmH~2~O. Anesthesia was maintained with desflurane 0.8--1.0 × minimum alveolar concentration, with a mixture of air and oxygen with an oxygen concentration of 50--60 % to maintain the bispectral index between 40 and 60. At the beginning of surgery, dexamethasone 8 mg and metamizole 2.5 g were administered as an antiemetic and analgesic, respectively. Following anastomosis of the intestinal organs, ondansetron 8 mg and oxycodone 10 mg were administered intravenously.

A maximum of 1,000 ml of balanced crystalloid solution was administered during surgery. Both desflurane and remifentanil were discontinued at a pre-defined point according to the type of surgery. On completion of surgery, a combination of atropine and neostigmine, or sugammadex alone was administered for reversal of neuromuscular blockade. The endotracheal tube was removed after confirming the TOF ratio \>90 %, SpO~2~ \>92 %, PaO~2~ \>60 mmHg, adequate ventilation, stable blood pressure and heart rate, usually within 5 min after surgery. The patients were moved to their bed unaided by medical personnel and were transferred to the PACU.

After anesthesia {#Sec6}
================

On the PACU, patients received dexamethasone 8 mg and ondansetron 8 mg. The level of pain was evaluated using a visual analog scale. Patients who leave the PACU are transported to the surgical ward after confirming PACU discharge criteria---(1) respond to verbal stimuli, and (2) respiratory rate 10--20/min, SpO2 \>95 % (at room air), and heart rate 60--90 bpm. Patients are encouraged to leave their bed and move around independently by the nurses to minimize the risk of venous thrombosis, and are discharged as soon as satisfying the following conditions, without complications during anesthesia and surgery---(1) heart rate \<100 bpm, (2) respiratory rate \<20/min, (3) body temperature \<38 °C, (4) VAS \<4/10 with acetaminophen 4 g daily, (5) recovery of full mobility, being able to independently perform basic activities, and (6) C-reactive protein \<100 mg/l or decrease compared with the first postoperative measurements and the number of leucocytes \<20,000/µl. On the surgical ward, patients were administered a daily dose of acetaminophen 4 g or tramadol 150 mg, and additional paracetamol 150 mg or diclofenac 150 mg followed by dexamethasone 8 mg, metoclopramide 30 mg, ondansetron 12 mg and pantoprazole 80 mg. The patients were required to visit our hospital 1, 4 and 12 months after discharge for follow-up.

A total of 374 patients were included in this study---228 underwent surgery following the pre-ERABS protocol and 146 following the ERABS protocol. Of the 374 patients, 186, 144, 31 and 13 underwent gastric bypass, sleeve gastrectomy, gastric band and revisional surgery, respectively. There were no differences in baseline demographic or co-morbidity data between the two groups of patients (Table [1](#Tab1){ref-type="table"}). The length of stay in the hospital was significantly shortened from 3.7 (95 % CI 3.1--4.7) days to 2.1 (95 % CI 1.6--2.6) days (*p* \< 0.001) following the ERABS protocol compared to the pre-ERABS protocol. Procedure (surgical) times were shortened by 15 (7) min and 12 (5) min for gastric bypass and gastric sleeve surgery, respectively (*P* \< 0.001 for both), by introducing the ERABS protocol. Induction times were reduced from 15.2 (95 % CI 14.3--16.1) min to 12.5 (95 % CI 11.7--13.3) min (*P* \< 0.001). Turnover times shortened significantly from 38 (95 % CI 44--32) min to 11 (95 % CI 8--14) min. The incidence of re-operations, readmissions and complications within 30 days after discharge did not change after implementation of the ERABS protocol (Table [2](#Tab2){ref-type="table"}). The reduction in the length of stay in hospital can be explained by the change in the anesthesia protocol; this ensured that the patient became mobile as soon as possible following the surgical procedure, quickly regaining full mobility, including oral food intake. The procedure time decreased by shortening the induction time and surgical time but also as a result of introducing the 'working with a fixed team' concept. A dedicated group of surgeons, anesthesiologist and circulating nurses worked together. Instead of operating on two to four patients per day on several days of the week with different anesthesiologist and nurses, the team now works together all day for 2 days per week. This contributes to team cohesion and may increase the team work and safety climate and productivity \[[@CR9], [@CR10]\]. In conclusion, our study confirms that the use of ERABS makes it possible to create centers which are able to process a large number of bariatric cases and at the same time maintain the quality as well as efficiency of surgery, while ensuring the highest safety standards \[[@CR11], [@CR12]\].Table 1Baseline demographic and co-morbidity dataPre-ERABSERABS*P* valueNo. of patients228146Age (years)44  ±  1043  ±  110.365^a^Length of stay in hospital (days)3.7 ± 0.42.1 ± 0.5\<0.001No. of male patients141 (62 %)85 (58 %)0.485^b^Body mass index (kg/m^2^)45.1 ± 4.644.4 ± 4.70.154^a^Visual analog score2.6 ± 1.42.4 ± 1.10.145^a^Medical co-morbidity, no. (%)^b^ Hypertension91 (39.8 %)65 (44.5 %)0.388 Type 2 diabetes mellitus59 (25.9 %)51 (34.9 %)0.061 Obstructive sleep apnea37 (16.2 %)22 (15.1 %)0.764 Current smoker68 (29.8 %)45 (30.8 %)0.838 COPD22 (9.6 %)16 (11.7 %)0.683 GERD46 (20.1 %)24 (16.4 %)0.366 Dyslipidemia34 (14.9 %)13 (8.9 %)0.087Primary procedures^b^ Gastric bypass113 (49.6 %)73 (50 %)0.934 Sleeve gastrectomy89 (39.0 %)55 (37.7 %)0.791 Gastric band18 (7.9 %)13 (8.9 %)0.730 Revisional8 (3.5 %)5 (3.4 %)0.965Values are expressed as mean ± standard deviation or absolute value (%)*COPD* chronic obstructive pulmonary disease, *GERD* gastroesophageal reflux disease^a^Using independent *t* tests^b^Using chi-squared testTable 2Complications, re-admissions and re-operationsWithin 30 days after dischargePre-ERABSERABS*P* value^a^No. of patients228146Clavien−Dindo classification complications^b^ Minor20 (8.77 %)15 (10.27 %)0.626 Grade I12 (5.26 %)8 (5.48 %)0.928 Grade II8 (3.51 %)7 (4.79 %)0.672 Major6 (2.63 %)4 (2.74 %)0.958 Grade IIIa2 (0.88 %)1 (0.68 %)0.834 Grade IIIb2 (0.88 %)2 (1.37 %)0.656 Grade IVa1 (0.44 %)1 (0.68 %)0.754 Grade IVb1 (0.44 %)0 (0.00 %)0.421 Re-admissions8 (3.51 %)4 (2.74 %)0.672 Re-operations3 (1.32 %)2 (1.37 %)0.971 Mortality1 (0.44 %)0 (0.00 %)0.421^a^Using chi-squared test^b^ Grade I: any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions. Acceptable therapeutic regimens are drugs as anti-emetics, antipyretics, analgetics, diuretics and electrolytes and physiotherapy. This grade also includes wound infections opened at the bedside. Grade II: requiring pharmacological treatment with drugs other than such allowed for grade I complications. Blood transfusions and total parenteral nutrition are also included. Grade III: requiring surgical, endoscopic or radiological intervention. Grade III-a: intervention not under general anesthesia. Grade III-b: intervention under general anesthesia. Grade IV: life-threatening complication requiring IC/ICU management. Grade IV-a: single organ dysfunction (including dialysis). Grade IV-b: multi organ dysfunction. Grade V: death of a patient \[7.8\]
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